Evening hot spots in A shares: Goldman Sachs and Morgan Stanley warn that global stock markets may experience a correction of at least 10%. Chinese stocks are once again gaining favor.
Goldman Sachs and Morgan Stanley both warned investors on Tuesday that the market will experience a downturn in the next two years. Goldman Sachs CEO David Solomon said, "At some point in the next 12 to 24 months, we could likely see a 10% to 20% pullback."
1. Have 9 days off, "the longest Spring Festival" is coming
Importance:
The General Office of the State Council issued a notice on the arrangement of some holidays in 2026 on November 4th. Among them, the Spring Festival holiday is from February 15th to February 23rd, a total of 9 days, making it the "longest Spring Festival holiday" in history.
It is worth noting that less than half an hour after the news was released, the search volume for train tickets and international flights during the New Year and Spring Festival period on online travel booking platforms instantly doubled and continued to rise.
Comment: This Spring Festival holiday arrangement is quite beyond expectations! A continuous 9-day holiday, and starting resting from the lunar twenty-eighth month, allowing everyone to have more time to prepare for the New Year and reunion. If you can add a few more days off, you will have half a month of rest time. No wonder the moment the news came out, the search volume for plane tickets instantly increased. Zixuan thinks it's pretty good, giving netizens more time to rest, bringing good news to the tourism sector, and allowing investors to have some fun...
2. Goldman Sachs, Morgan Stanley warn global stock markets may see at least a 10% pullback, China stocks are optimistic again
Importance:
After experiencing a sharp rise since the beginning of the year, global stock markets may face a reality check. Both Goldman Sachs and Morgan Stanley warned investors on Tuesday that there will be a pullback in the market over the next two years.
"It is likely that there will be a 10% to 20% pullback at some point in the next 12 to 24 months," Goldman Sachs CEO David Solomon said at the Global Financial Leaders Investment Summit in Hong Kong. "The market will pull back after going up so that people can re-evaluate."
However, Goldman Sachs predicts that global allocators will continue to be interested in China, and also adds that China remains one of the world's "largest and most important economies." Morgan Stanley still remains optimistic about the Chinese, Japanese, and Indian stock markets as they each have unique growth narratives.
Comment: On Tuesday, global risk assets fell: Nasdaq 100 futures fell more than 1%, European stocks fell more than 1%, cryptocurrencies continue to collapse, gold, silver, and oil all fell, and the dollar remains at around 100. Previously, people often talked about the three great illusions of life: A-shares will rise, US stocks will fall, and "ta" still loves me. Zixuan feels that these illusions may need to be revised in the future...
(Continued in next message)
Related Articles

Infotmic Co., Ltd. shareholder Orient intends to reduce its shareholding by no more than 3%.

US Stock Market Move | Palantir (PLTR.US) fell more than 6.7% in response to its impressive Q3 financial report, but the market is concerned that its valuation is too high.

US Stock Market Move | Royal Philips N.V. Sponsored ADR (PHG.US) rises 3% in Q3, adjusted EBITA exceeds expectations.
Infotmic Co., Ltd. shareholder Orient intends to reduce its shareholding by no more than 3%.

US Stock Market Move | Palantir (PLTR.US) fell more than 6.7% in response to its impressive Q3 financial report, but the market is concerned that its valuation is too high.

US Stock Market Move | Royal Philips N.V. Sponsored ADR (PHG.US) rises 3% in Q3, adjusted EBITA exceeds expectations.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


